Body Protection Compound 157, PL 14736. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 200 mcg | daily | 0.12 mL | 12 u | 14 | 2.8 mg |
| Weeks 3–4 | 250 mcg | daily | 0.15 mL | 15 u | 14 | 3.5 mg |
| Week 5 onward per 4 weeks from here on |
500 mcg | daily | 0.3 mL | 30 u | 28 | 14 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Low reported | 200 mcg | 1× daily | 0.12 mL | 12 u | 25 doses |
| Commonly reported | 250 mcg | 1–2× daily | 0.15 mL | 15 u | 20 doses |
| Upper reported | 500 mcg | 1–2× daily | 0.3 mL | 30 u | 10 doses |
| Research study dose | 10 mcg/kg | daily, 7–21 d | Set by body weight — can't be turned into a single amount to draw | ||
A pentadecapeptide fragment derived from a sequence in human gastric juice. The published record is almost entirely preclinical research on tendon, ligament, muscle and gastrointestinal healing. There is no completed, published human efficacy trial, and reported doses are extrapolations from weight-based research figures rather than clinically established ranges.
Buy BPC-157Paid affiliate links.
Adding 3 mL of bacteriostatic water to a 5 mg vial gives 1.67 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for BPC-157 run from 200 mcg to 500 mcg, typically 1× daily. This site lists each figure with the source it came from rather than giving a single recommended number.
At 1.67 mg/mL, a 200 mcg dose is 12 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 25 doses.
BPC-157 is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Need this on one page to print, screenshot or send?
Make a dose card →Side-by-side with the compounds it is most often weighed against — doses, evidence tier and how each is mixed.
Compounds in the same class, or browse the full catalogue.
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied for anti-inflammatory activity in colitis and dermatitis mo…
A synthetic fragment of thymosin beta-4, the actin-sequestering protein. Full-length Tβ4 reached human trials for dry eye and card…
Every compound compared in one table: dose range, how often, half-life and evidence tier.